Compare, Analyse Orchid Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs ACTAVIS (US) - Comparison Results

ORCHID PHARMA     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA   ACTAVIS
EQUITY SHARE DATA
    ORCHID PHARMA
Sep-13
ACTAVIS
Dec-18
ORCHID PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs19414,487-   
Low Rs359,718-   
Sales per share (Unadj.) Rs276.53,553.7-  
Earnings per share (Unadj.) Rs-79.2-1,144.7-  
Cash flow per share (Unadj.) Rs-43.5374.5-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.914,657.5-  
Shares outstanding (eoy) m70.45332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.43.4 12.2%   
Avg P/E ratio x-1.4-10.6 13.7%  
P/CF ratio (eoy) x-2.632.3 -8.2%  
Price / Book Value ratio x2.10.8 257.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0674,025,370 0.2%   
No. of employees `0002.816.9 16.6%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.169,939.2 9.9%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.0-22,527.5 8.8%   
INCOME DATA
Net Sales Rs m19,4771,181,973 1.6%  
Other income Rs m40722,603 1.8%   
Total revenues Rs m19,8841,204,576 1.7%   
Gross profit Rs m1,10330,974 3.6%  
Depreciation Rs m2,519505,268 0.5%   
Interest Rs m5,22768,207 7.7%   
Profit before tax Rs m-6,236-519,897 1.2%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511132,595 0.4%   
Tax Rs m-125-6,589 1.9%   
Profit after tax Rs m-5,580-380,714 1.5%  
Gross profit margin %5.72.6 216.0%  
Effective tax rate %2.01.3 158.4%   
Net profit margin %-28.7-32.2 88.9%  
BALANCE SHEET DATA
Current assets Rs m11,014484,783 2.3%   
Current liabilities Rs m32,060428,855 7.5%   
Net working cap to sales %-108.14.7 -2,283.6%  
Current ratio x0.31.1 30.4%  
Inventory Days Days9520 484.5%  
Debtors Days Days3466 50.6%  
Net fixed assets Rs m29,440133,793 22.0%   
Share capital Rs m7050-   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,8004,875,085 0.1%   
Long term debt Rs m9,0181,716,694 0.5%   
Total assets Rs m46,5107,620,868 0.6%  
Interest coverage x-0.2-6.6 2.9%   
Debt to equity ratio x2.40.4 673.9%  
Sales to assets ratio x0.40.2 270.0%   
Return on assets %-0.8-4.1 18.5%  
Return on equity %-146.9-7.8 1,880.5%  
Return on capital %-3.7-4.8 77.1%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682422,274 0.4%  
From Investments Rs m-9,860231,985 -4.3%  
From Financial Activity Rs m6,644-724,749 -0.9%  
Net Cashflow Rs m-1,535-70,138 2.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.87 Rs / USD

Compare ORCHID PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA With: DR. REDDYS LAB  LUPIN  FULFORD INDIA  NOVARTIS  TORRENT PHARMA  



Today's Market

Sensex Trades On a Volatile Note, Dow Futures Up by 68 Points(12:30 pm)

Share markets in India are presently trading on a volatile note. The BSE Sensex is trading up by 11 points, flat, at 47,960 levels.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Warning About Bubbles (Fast Profits Daily)

Apr 16, 2021

Those who don't learn from financial history are doomed to lose their money.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ORCHID PHARMA SHARE PRICE


Apr 20, 2021 03:02 PM

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA 8-QTR ANALYSIS

COMPARE ORCHID PHARMA WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS